Cargando…

PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

Detalles Bibliográficos
Autores principales: Han, Xiao, Wen, Qin, Wan, Kai, Liu, Xue, Yan, Hongju, Tan, Xu, Bao, Yang, Zhang, Cheng, Zhang, XI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430140/
http://dx.doi.org/10.1097/01.HS9.0000974264.90665.ad
_version_ 1785090884556029952
author Han, Xiao
Wen, Qin
Wan, Kai
Liu, Xue
Yan, Hongju
Tan, Xu
Bao, Yang
Zhang, Cheng
Zhang, XI
author_facet Han, Xiao
Wen, Qin
Wan, Kai
Liu, Xue
Yan, Hongju
Tan, Xu
Bao, Yang
Zhang, Cheng
Zhang, XI
author_sort Han, Xiao
collection PubMed
description
format Online
Article
Text
id pubmed-10430140
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104301402023-08-17 PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA Han, Xiao Wen, Qin Wan, Kai Liu, Xue Yan, Hongju Tan, Xu Bao, Yang Zhang, Cheng Zhang, XI Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430140/ http://dx.doi.org/10.1097/01.HS9.0000974264.90665.ad Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Han, Xiao
Wen, Qin
Wan, Kai
Liu, Xue
Yan, Hongju
Tan, Xu
Bao, Yang
Zhang, Cheng
Zhang, XI
PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
title PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
title_full PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
title_fullStr PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
title_full_unstemmed PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
title_short PB1857: VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
title_sort pb1857: venetoclax, azacitidine, combined with low-dose cytarabine in olderly or unfit patients with newly diagnosed acute myeloid leukemia
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430140/
http://dx.doi.org/10.1097/01.HS9.0000974264.90665.ad
work_keys_str_mv AT hanxiao pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT wenqin pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT wankai pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT liuxue pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT yanhongju pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT tanxu pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT baoyang pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT zhangcheng pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia
AT zhangxi pb1857venetoclaxazacitidinecombinedwithlowdosecytarabineinolderlyorunfitpatientswithnewlydiagnosedacutemyeloidleukemia